QDENGA Summary of Product Characteristics. Retrieved August 2022.(武田,QDENGA产品特性总结。检索于2022年8月)2 World Health Organization. Fact Sheet. Dengue and Severe Dengue. January 2022. Retrieved August 2022.(世界卫生组织。事实清单。2022年1月。检索于2022年8月)3 Shepard DS, Undurraga EA, ...
11 Takeda.QDENGA Summary of Product Characteristics. Retrieved August 2022.(武田,QDENGA產品特性總結。檢索於2022年8月) 2World Health Organization. Fact Sheet.Dengue and Severe Dengue. January 2022. Retrieved August 2022.(世界衛生組織。事實清單。2022年1月。檢索於2022年8月) 3Shepard DS, Undurraga ...
iTakeda.QDENGA Summary of Product Characteristics. Retrieved December 2022. (武田,QDENGA產品特性總結。檢索於2022年12月) iiWorld Health Organization.Dengue and Severe Dengue. January 2022. Retrieved December 2022. (世界衛生組織。登革熱與重症登革熱。2022年1月。檢索於2022年12月) iiiEuropean Centre for...
Please consult the Summary of Product Characteristics (SmPC) before prescribing. Guidance for use: QDENGA should be administered by subcutaneous injection preferably in the upper arm in the region of deltoid. QDENGA must not be injected intravascularly, intradermally or ...
Please consult the Summary of Product Characteristics (SmPC) before prescribing. Guidance for use: QDENGA should be administered by subcutaneous injection preferably in the upper arm in the region of deltoid. QDENGA must not be injected intravascularly, intradermally or intramuscularly. Vaccination ...
1 1 Takeda. QDENGA Summary of Product Characteristics. Retrieved August 2022.(武田,QDENGA产品特性总结。检索于2022年8月) 2 World Health Organization. Fact Sheet. Dengue and Severe Dengue. January 2022. Retrieved August 2022.(世界卫生组织。事实清单。2022年1月。检索于2022年8月) ...
Please consult the Summary of Product Characteristics (SmPC) before prescribing. Guidance for use: QDENGA should be administered by subcutaneous injection preferably in the upper arm in the region of deltoid. QDENGA must not be injected intravascularly, intradermally or intramuscularly. Vaccination sho...